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Hossein Ajdarkosh1, Masoomeh Dadpay2, Emad Yahaghi3, Elham Rostami Pirzaman4, Amir Farshid Fayyaz5,
Ebrahim Khodaverdi Darian6 and Aram Mokarizadeh7*Retraction
The Editor-in-Chief and Publisher have retracted this
article [1] because the scientific integrity of the content
cannot be guaranteed. An investigation by the Publisher
found it to be one of a group of articles we have identified
as showing evidence suggestive of attempts to subvert the
peer review and publication system to inappropriately ob-
tain or allocate authorship. This article showed evidence
of plagiarism (most notably from the articles cited [2, 3])
and authorship manipulation.
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